NEW YORK, March 21 (GenomeWeb News) - BSI Proteomics said last week that it will perform protein crystallization and structure determination services for the Cystic Fibrosis Foundation.
The foundation selected BSI to express, purify, crystallize, and determine the structure of the cystic fibrosis trans-conductance protein, a membrane protein that has proved difficult to purify, according to the Gaithersburg, MD.-based firm.
BSI will use its Membrane Protein Stabilization System, which has particular capabilities for stabilizing membrane, ion-channel, and other "difficult" soluble proteins, the company said. BSI claims that its technology can produce diffractable crystals in months, compared to years required for other methods.
The company did not disclose any financial terms for its agreement with the Cystic Fibrosis Foundation.